Un modèle d’analyse de généalogie ascendante

Cet article présente un modèle de généalogie ascendante, la définition et l’évaluation des fonctions qui permettent d’en faire l’étude, ainsi que les principaux algorithmes développés pour en faire des outils de travail sur micro-ordinateur. Les exemples de fonctions d’extraction de résultats destinés à l’analyse d’ascendances illustrent la portée de la mise au point du modèle, que ce soit pour la sortie de listes ou le calcul des coefficients de consanguinité et de complétude.This paper presents a model of ascending genealogies, with the definition and investigation of the functions allowing for the study of these genealogies as well as with the main algorithms used in operationalizing the model on a micro-computer. Examples of the type of results one may obtain with this model are provided; they concern file outputs as well as the computation of consanguinity and completeness coefficients.Este artículo presenta un modelo de genealogía ascendente, la definición y la evaluación de funciones que permiten estudiar el mismo asi como los principales algoritmos desarrollados para hacer de ellos herramientas de trabajo para micro-computadora. Los ejemplos de funciones de extracción de resultados destinados al análisis de ascendencias illustran la amplitud de puesta a punto del modelo, sea por la salida de listas o por el cálculo de coeficientes de consanguinidad y de completitud

Un programme de recherches sur la dynamique bioculturelle

L’objectif du programme présenté est de mettre en lumière les interactions des facteurs biologiques et sociaux dans les processus de renouvellement des populations. Les registres de population de plusieurs communautés, dont celles de l’île Saint-Barthélémy (Antilles françaises) et de l’Île-aux-Coudres (Québec), servent de base aux études envisagées. Les généalogies qu’on en tire sont mises à contribution plus spécifiquement pour des études en épidémiologie génétique. Une démarche complémentaire consiste à identifier les facteurs sociaux qui ont contribué à la structuration biologique des communautés.The objective of the research program presented in this note is to analyse the interrelations between biological and social factors in the process of demographic renewal. Population registers of various communities, among them those of Saint-Barthélémy (French Antilles) and Ile-aux-Coudres (Quebec), are used. The genealogies which were obtained from these registers contribute to the study of genetical epidemiology. The research program also includes the identification of social factors which may have contributed to the biological structure of the communities under study.El objetivo del programa presentado es de clarificar las interacciones de los factores biológicos y sociales en los procesos de renuevo de las poblaciones. Los registros de población de muchas comunidades, entre ellas la de la isla Saint-Barthélémy (Antillas Francesas) y de la "Ile-aux-Coudres" (Québec), sirven de base a los estudios encarados. Las genealogías que se extraen de ellos contribuyen más especificamente a estudios en epidemiologiá genética. Un proceso complementario consiste a identificar los factores sociales que han contribuido a la estructuracion biológica de las comunidades

Mass spectrometry imaging identifies palmitoylcarnitine as an immunological mediator during Salmonella Typhimurium infection

Salmonella Typhimurium causes a self-limiting gastroenteritis that may lead to systemic disease. Bacteria invade the small intestine, crossing the intestinal epithelium from where they are transported to the mesenteric lymph nodes (MLNs) within migrating immune cells. MLNs are an important site at which the innate and adaptive immune responses converge but their architecture and function is severely disrupted during S. Typhimurium infection. To further understand host-pathogen interactions at this site, we used mass spectrometry imaging (MSI) to analyse MLN tissue from a murine model of S. Typhimurium infection. A molecule, identified as palmitoylcarnitine (PalC), was of particular interest due to its high abundance at loci of S. Typhimurium infection and MLN disruption. High levels of PalC localised to sites within the MLNs where B and T cells were absent and where the perimeter of CD169+ sub capsular sinus macrophages was disrupted. MLN cells cultured ex vivo and treated with PalC had reduced CD4+CD25+ T cells and an increased number of B220+CD19+ B cells. The reduction in CD4+CD25+ T cells was likely due to apoptosis driven by increased caspase-3/7 activity. These data indicate that PalC significantly alters the host response in the MLNs, acting as a decisive factor in infection outcome

Age influence on effectiveness of a novel 3-phytase in barley-wheat based diets for pigs from 12 to 108 kg under commercial conditions

[EN] The main objective of this study was to evaluate the influence of pig's age on the effectiveness of a new microbial 3-phytase, produced by Komagataella phaffii, under commercial conditions in barley-wheat based diets. Two experiments were conducted in weaned, growing and finishing pigs; firstly, to determine phytase efficacy on dry matter, organic matter, energy, protein and mineral (phosphorus, P and calcium, Ca) digestibility (n = 48; Experiment 1), and secondly, to evaluate the effect of phytase on growth performance and bone mineralization (n = 312; Experiment 2). In each experiment, three barley-wheat based diets were formulated following the recommendations for each animal age, of which two versions were manufactured, including 0 and 1000 phytase units (FTU)/kg of feed of the new 3-phytase to be tested. Results showed the new phytase had the potential to increase the digestibility of Ca and P (on av. + 0.05 and +0.06, respectively; P < 0.01), especially P digestibility in growing pigs (+0.10; P < 0.001), consequently decreasing P and Ca excretion. Digestible energy (DE) of the diet increased with the addition of phytase in weaned pigs (+0.69 MJ/kg of dry matter (DM); P < 0.001). Dietary inclusion of new 3-phytase enhanced average daily gain from 46 to 94 days of age (+0.07 kg/d; P < 0.05) and decreased feed conversion ratio from 46 to 154 days of age (on av. -0.13; P < 0.05), although no significant effect was observed from 154 to 185 days of age. Addition of the new 3-phytase also promoted bone mineralization, increasing the weight of the bones (+3.99 and +3.64 g of tibia at 95 days and metacarpus at 100 days of age, respectively; P < 0.05) and the ash, Ca and P content in these bones (e.g. + 0.46 and +0.33 g of P in tibia at 95 days and metacarpus at 100 days of age, respectively; P < 0.001). In conclusion, pig age affected the efficacy of a new 3-phytase on P and Ca digestibility both in weaned and growing diets and DE content of the weaned diets, which also resulted in improvements in growth, feed conversion and bone development until 154 days of age. These effects seem to be reduced during the finishing period, although the advantages of the new 3-phytase on bone mineralization were maintained until 185 days of age.We thank the technical staff at the experimental farms of the Research and Technology Animal Centre (CITA-IVIA), the Institute of Animal Science and Technology (Universitat Politècnica de Valencia) and Javier Gómez (Crianzas Campovivo) for expert technical assistance and experimental support.Cambra López, M.; Cerisuelo, A.; Ferrer, P.; Ródenas Martínez, L.; Aligué, R.; Moset, V.; Pascual Amorós, JJ. (2020). Age influence on effectiveness of a novel 3-phytase in barley-wheat based diets for pigs from 12 to 108 kg under commercial conditions. Animal Feed Science and Technology. 267:1-13. https://doi.org/10.1016/j.anifeedsci.2020.114549S113267Adeola, O., & Cowieson, A. J. (2011). BOARD-INVITED REVIEW: Opportunities and challenges in using exogenous enzymes to improve nonruminant animal production. Journal of Animal Science, 89(10), 3189-3218. doi:10.2527/jas.2010-3715Almeida, F. N., Sulabo, R. C., & Stein, H. H. (2013). Effects of a novel bacterial phytase expressed in Aspergillus Oryzae on digestibility of calcium and phosphorus in diets fed to weanling or growing pigs. Journal of Animal Science and Biotechnology, 4(1). doi:10.1186/2049-1891-4-8Arredondo, M. A., Casas, G. A., & Stein, H. H. (2019). Increasing levels of microbial phytase increases the digestibility of energy and minerals in diets fed to pigs. Animal Feed Science and Technology, 248, 27-36. doi:10.1016/j.anifeedsci.2019.01.001Atakora, J. K. A., Moehn, S., Sands, J. S., & Ball, R. O. (2011). Effects of dietary crude protein and phytase–xylanase supplementation of wheat grain based diets on energy metabolism and enteric methane in growing finishing pigs. Animal Feed Science and Technology, 166-167, 422-429. doi:10.1016/j.anifeedsci.2011.04.030Blaabjerg, K., Nørgaard, J. V., & Poulsen, H. D. (2012). Effect of microbial phytase on phosphorus digestibility in non-heat-treated and heat-treated wheat–barley pig diets1. Journal of Animal Science, 90(suppl_4), 206-208. doi:10.2527/jas.53920Brady, S., Callan, J., Cowan, D., McGrane, M., & O’Doherty, J. (2002). Effect of phytase inclusion and calcium/phosphorus ratio on the performance and nutrient retention of grower-finisher pigs fed barley/wheat/soya bean meal-based diets. Journal of the Science of Food and Agriculture, 82(15), 1780-1790. doi:10.1002/jsfa.1262Braña, D. V., Ellis, M., Castañeda, E. O., Sands, J. S., & Baker, D. H. (2006). Effect of a novel phytase on growth performance, bone ash, and mineral digestibility in nursery and grower-finisher pigs. Journal of Animal Science, 84(7), 1839-1849. doi:10.2527/jas.2005-565Dersjant‐Li, Y., Awati, A., Schulze, H., & Partridge, G. (2014). Phytase in non‐ruminant animal nutrition: a critical review on phytase activities in the gastrointestinal tract and influencing factors. Journal of the Science of Food and Agriculture, 95(5), 878-896. doi:10.1002/jsfa.6998Eeckhout, W., & De Paepe, M. (1994). Total phosphorus, phytate-phosphorus and phytase activity in plant feedstuffs. Animal Feed Science and Technology, 47(1-2), 19-29. doi:10.1016/0377-8401(94)90156-2EMIOLA, A., AKINREMI, O., SLOMINSKI, B., & NYACHOTI, C. M. (2009). Nutrient utilization and manure P excretion in growing pigs fed corn-barley-soybean based diets supplemented with microbial phytase. Animal Science Journal, 80(1), 19-26. doi:10.1111/j.1740-0929.2008.00590.xGonzález-Vega, J. C., Walk, C. L., & Stein, H. H. (2015). Effects of microbial phytase on apparent and standardized total tract digestibility of calcium in calcium supplements fed to growing pigs1. Journal of Animal Science, 93(5), 2255-2264. doi:10.2527/jas.2014-8215Harper, A. F., Kornegay, E. T., & Schell, T. C. (1997). Phytase supplementation of low-phosphorus growing-finishing pig diets improves performance, phosphorus digestibility, and bone mineralization and reduces phosphorus excretion. Journal of Animal Science, 75(12), 3174. doi:10.2527/1997.75123174xHaug, W., & Lantzsch, H.-J. (1983). Sensitive method for the rapid determination of phytate in cereals and cereal products. Journal of the Science of Food and Agriculture, 34(12), 1423-1426. doi:10.1002/jsfa.2740341217Heaney, R. P., Abrams, S., Dawson-Hughes, B., Looker, A., Looker, A., Marcus, R., … Weaver, C. (2001). Peak Bone Mass. Osteoporosis International, 11(12), 985-1009. doi:10.1007/s001980070020Jørgensen, B. (1995). Effect of different energy and protein levels on leg weakness and osteochondrosis in pigs. Livestock Production Science, 41(2), 171-181. doi:10.1016/0301-6226(94)00048-cKemme, P. A., Jongbloed, A. W., Mroz, Z., & Beynen, A. C. (1997). The efficacy of Aspergillus niger phytase in rendering phytate phosphorus available for absorption in pigs is influenced by pig physiological status. Journal of Animal Science, 75(8), 2129. doi:10.2527/1997.7582129xKiela, P. R., & Ghishan, F. K. (2016). Physiology of Intestinal Absorption and Secretion. Best Practice & Research Clinical Gastroenterology, 30(2), 145-159. doi:10.1016/j.bpg.2016.02.007Kim, J. C., Simmins, P. H., Mullan, B. P., & Pluske, J. R. (2005). The effect of wheat phosphorus content and supplemental enzymes on digestibility and growth performance of weaner pigs. Animal Feed Science and Technology, 118(1-2), 139-152. doi:10.1016/j.anifeedsci.2004.08.016Koch, M. E., & Mahan, D. C. (1985). Biological Characteristics for Assessing Low Phosphorus Intake in Growing Swine. Journal of Animal Science, 60(3), 699-708. doi:10.2527/jas1985.603699xKonietzny, U., & Greiner, R. (2002). Molecular and catalytic properties of phytate-degrading enzymes (phytases). International Journal of Food Science and Technology, 37(7), 791-812. doi:10.1046/j.1365-2621.2002.00617.xLittell, R. C., Henry, P. R., & Ammerman, C. B. (1998). Statistical analysis of repeated measures data using SAS procedures. Journal of Animal Science, 76(4), 1216. doi:10.2527/1998.7641216xMahan, D. C. (1982). Dietary Calcium and Phosphorus Levels for Weanling Swine. Journal of Animal Science, 54(3), 559-564. doi:10.2527/jas1982.543559xMavromichalis, I., Hancock, J. D., Kim, I. H., Senne, B. W., Kropf, D. H., Kennedy, G. A., … Behnke, K. C. (1999). Effects of omitting vitamin and trace mineral premixes and(or) reducing inorganic phosphorus additions on growth performance, carcass characteristics, and muscle quality in finishing pigs. Journal of Animal Science, 77(10), 2700. doi:10.2527/1999.77102700xMoehn, S., Atakora, J. K. A., Sands, J., & Ball, R. O. (2007). Effect of phytase-xylanase supplementation to wheat-based diets on energy metabolism in growing–finishing pigs fed ad libitum. Livestock Science, 109(1-3), 271-274. doi:10.1016/j.livsci.2007.01.118Oryschak, M. A., Simmins, P. H., & Zijlstra, R. T. (2002). Effect of dietary particle size and carbohydrase and/or phytase supplementation on nitrogen and phosphorus excretion of grower pigs. Canadian Journal of Animal Science, 82(4), 533-540. doi:10.4141/a02-016Peter, C. ., Parr, T. ., Parr, E. ., Webel, D. ., & Baker, D. . (2001). The effects of phytase on growth performance, carcass characteristics, and bone mineralization of late-finishing pigs fed maize–soyabean meal diets containing no supplemental phosphorus, zinc, copper and manganese. Animal Feed Science and Technology, 94(3-4), 199-205. doi:10.1016/s0377-8401(01)00300-5Rodehutscord, M., Faust, M., & Lorenz, H. (1996). Digestibility of phosphorus contained in soybean meal, barley, and different varieties of wheat, without and with supplemental phytase fed to pigs and additivity of digestibility in a wheatsoybean-meal diet. Journal of Animal Physiology and Animal Nutrition, 75(1-5), 40-48. doi:10.1111/j.1439-0396.1996.tb00466.xSelle, P. H., & Ravindran, V. (2008). Phytate-degrading enzymes in pig nutrition. Livestock Science, 113(2-3), 99-122. doi:10.1016/j.livsci.2007.05.014Selle, P. H., Cadogan, D. J., & Bryden, W. L. (2003). Effects of phytase supplementation of phosphorus-adequate, lysine-deficient, wheat-based diets on growth performance of weaner pigs. Australian Journal of Agricultural Research, 54(3), 323. doi:10.1071/ar02121She, Y., Su, Y., Liu, L., Huang, C., Li, J., Li, P., … Piao, X. (2015). Effects of microbial phytase on coefficient of standardized total tract digestibility of phosphorus in growing pigs fed corn and corn co-products, wheat and wheat co-products and oilseed meals. Animal Feed Science and Technology, 208, 132-144. doi:10.1016/j.anifeedsci.2015.07.011Van Soest, P. J., Robertson, J. B., & Lewis, B. A. (1991). Methods for Dietary Fiber, Neutral Detergent Fiber, and Nonstarch Polysaccharides in Relation to Animal Nutrition. Journal of Dairy Science, 74(10), 3583-3597. doi:10.3168/jds.s0022-0302(91)78551-2Varley, P. F., Callan, J. J., & O’Doherty, J. V. (2011). Effect of dietary phosphorus and calcium level and phytase addition on performance, bone parameters, apparent nutrient digestibility, mineral and nitrogen utilization of weaner pigs and the subsequent effect on finisher pig bone parameters. Animal Feed Science and Technology, 165(3-4), 201-209. doi:10.1016/j.anifeedsci.2011.02.017Varley, P. F., Flynn, B., Callan, J. J., & O’Doherty, J. V. (2011). Effect of phytase level in a low phosphorus diet on performance and bone development in weaner pigs and the subsequent effect on finisher pig bone development. Livestock Science, 138(1-3), 152-158. doi:10.1016/j.livsci.2010.12.014Vipperman, P. E., Peo, E. R., & Cunningham, P. J. (1974). Effect of Dietary Calcium and Phosphorus Level upon Calcium, Phosphorus and Nitrogen Balance in Swine. Journal of Animal Science, 38(4), 758-765. doi:10.2527/jas1974.384758

Dual Neonate Vaccine Platform against HIV-1 and M. tuberculosis

Acquired immunodeficiency syndrome and tuberculosis (TB) are two of the world's most devastating diseases. The first vaccine the majority of infants born in Africa receive is Mycobacterium bovis bacillus Calmette-Guérin (BCG) as a prevention against TB. BCG protects against disseminated disease in the first 10 years of life, but provides a variable protection against pulmonary TB and enhancing boost delivered by recombinant modified vaccinia virus Ankara (rMVA) expressing antigen 85A (Ag85A) of M. tuberculosis is currently in phase IIb evaluation in African neonates. If the newborn's mother is positive for human immunodeficiency virus type 1 (HIV-1), the baby is at high risk of acquiring HIV-1 through breastfeeding. We suggested that a vaccination consisting of recombinant BCG expressing HIV-1 immunogen administered at birth followed by a boost with rMVA sharing the same immunogen could serve as a strategy for prevention of mother-to-child transmission of HIV-1 and rMVA expressing an African HIV-1-derived immunogen HIVA is currently in phase I trials in African neonates. Here, we aim to develop a dual neonate vaccine platform against HIV-1 and TB consisting of BCG.HIVA administered at birth followed by a boost with MVA.HIVA.85A. Thus, mMVA.HIVA.85A and sMVA.HIVA.85A vaccines were constructed, in which the transgene transcription is driven by either modified H5 or short synthetic promoters, respectively, and tested for immunogenicity alone and in combination with BCG.HIVA222. mMVA.HIVA.85A was produced markerless and thus suitable for clinical manufacture. While sMVA.HIVA.85A expressed higher levels of the immunogens, it was less immunogenic than mMVA.HIVA.85A in BALB/c mice. A BCG.HIVA222–mMVA.HIVA.85A prime-boost regimen induced robust T cell responses to both HIV-1 and M. tuberculosis. Therefore, proof-of-principle for a dual anti-HIV-1/M. tuberculosis infant vaccine platform is established. Induction of immune responses against these pathogens soon after birth is highly desirable and may provide a basis for lifetime protection maintained by boosts later in life

Protective Efficacy of Serially Up-Ranked Subdominant CD8+ T Cell Epitopes against Virus Challenges

Immunodominance in T cell responses to complex antigens like viruses is still incompletely understood. Some data indicate that the dominant responses to viruses are not necessarily the most protective, while other data imply that dominant responses are the most important. The issue is of considerable importance to the rational design of vaccines, particularly against variable escaping viruses like human immunodeficiency virus type 1 and hepatitis C virus. Here, we showed that sequential inactivation of dominant epitopes up-ranks the remaining subdominant determinants. Importantly, we demonstrated that subdominant epitopes can induce robust responses and protect against whole viruses if they are allowed at least once in the vaccination regimen to locally or temporally dominate T cell induction. Therefore, refocusing T cell immune responses away from highly variable determinants recognized during natural virus infection towards subdominant, but conserved regions is possible and merits evaluation in humans

Design and Pre-Clinical Evaluation of a Universal HIV-1 Vaccine

BACKGROUND: One of the big roadblocks in development of HIV-1/AIDS vaccines is the enormous diversity of HIV-1, which could limit the value of any HIV-1 vaccine candidate currently under test. METHODOLOGY AND FINDINGS: To address the HIV-1 variation, we designed a novel T cell immunogen, designated HIV(CONSV), by assembling the 14 most conserved regions of the HIV-1 proteome into one chimaeric protein. Each segment is a consensus sequence from one of the four major HIV-1 clades A, B, C and D, which alternate to ensure equal clade coverage. The gene coding for the HIV(CONSV) protein was inserted into the three most studied vaccine vectors, plasmid DNA, human adenovirus serotype 5 and modified vaccine virus Ankara (MVA), and induced HIV-1-specific T cell responses in mice. We also demonstrated that these conserved regions prime CD8(+) and CD4(+) T cell to highly conserved epitopes in humans and that these epitopes, although usually subdominant, generate memory T cells in patients during natural HIV-1 infection. SIGNIFICANCE: Therefore, this vaccine approach provides an attractive and testable alternative for overcoming the HIV-1 variability, while focusing T cell responses on regions of the virus that are less likely to mutate and escape. Furthermore, this approach has merit in the simplicity of design and delivery, requiring only a single immunogen to provide extensive coverage of global HIV-1 population diversity

A comprehensive assessment of somatic mutation detection in cancer using whole-genome sequencing.

As whole-genome sequencing for cancer genome analysis becomes a clinical tool, a full understanding of the variables affecting sequencing analysis output is required. Here using tumour-normal sample pairs from two different types of cancer, chronic lymphocytic leukaemia and medulloblastoma, we conduct a benchmarking exercise within the context of the International Cancer Genome Consortium. We compare sequencing methods, analysis pipelines and validation methods. We show that using PCR-free methods and increasing sequencing depth to ∼ 100 × shows benefits, as long as the tumour:control coverage ratio remains balanced. We observe widely varying mutation call rates and low concordance among analysis pipelines, reflecting the artefact-prone nature of the raw data and lack of standards for dealing with the artefacts. However, we show that, using the benchmark mutation set we have created, many issues are in fact easy to remedy and have an immediate positive impact on mutation detection accuracy.We thank the DKFZ Genomics and Proteomics Core Facility and the OICR Genome Technologies Platform for provision of sequencing services. Financial support was provided by the consortium projects READNA under grant agreement FP7 Health-F4-2008-201418, ESGI under grant agreement 262055, GEUVADIS under grant agreement 261123 of the European Commission Framework Programme 7, ICGC-CLL through the Spanish Ministry of Science and Innovation (MICINN), the Instituto de Salud Carlos III (ISCIII) and the Generalitat de Catalunya. Additional financial support was provided by the PedBrain Tumor Project contributing to the International Cancer Genome Consortium, funded by German Cancer Aid (109252) and by the German Federal Ministry of Education and Research (BMBF, grants #01KU1201A, MedSys #0315416C and NGFNplus #01GS0883; the Ontario Institute for Cancer Research to PCB and JDM through funding provided by the Government of Ontario, Ministry of Research and Innovation; Genome Canada; the Canada Foundation for Innovation and Prostate Cancer Canada with funding from the Movember Foundation (PCB). PCB was also supported by a Terry Fox Research Institute New Investigator Award, a CIHR New Investigator Award and a Genome Canada Large-Scale Applied Project Contract. The Synergie Lyon Cancer platform has received support from the French National Institute of Cancer (INCa) and from the ABS4NGS ANR project (ANR-11-BINF-0001-06). The ICGC RIKEN study was supported partially by RIKEN President’s Fund 2011, and the supercomputing resource for the RIKEN study was provided by the Human Genome Center, University of Tokyo. MDE, LB, AGL and CLA were supported by Cancer Research UK, the University of Cambridge and Hutchison-Whampoa Limited. SD is supported by the Torres Quevedo subprogram (MI CINN) under grant agreement PTQ-12-05391. EH is supported by the Research Council of Norway under grant agreements 221580 and 218241 and by the Norwegian Cancer Society under grant agreement 71220-PR-2006-0433. Very special thanks go to Jennifer Jennings for administrating the activity of the ICGC Verification Working Group and Anna Borrell for administrative support.This is the final version of the article. It first appeared from Nature Publishing Group via http://dx.doi.org/10.1038/ncomms1000